Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era
CompletedOBSERVATIONAL
Enrollment
95
Participants
Timeline
Start Date
July 30, 2017
Primary Completion Date
December 15, 2017
Study Completion Date
July 31, 2018
Conditions
Patient's Outcome Prognostic Factors
Trial Locations (1)
Unknown
Centre Hospitalier Lyon Sud, Hematology department, Pierre-Bénite
All Listed Sponsors
lead
Hospices Civils de Lyon
OTHER
NCT03663894 - Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era | Biotech Hunter | Biotech Hunter